Chen YM - Search Results

1

Luo YH, Chiu CH, Scott Kuo CH, Chou TY, Yeh YC, Hsu HS, Yen SH, Wu YH, Yang JC, Liao BC, Hsia TC, Chen YM. Luo YH, et al. Among authors: chen ym. J Thorac Oncol. 2021 Apr;16(4):519-527. doi: 10.1016/j.jtho.2020.10.155. J Thorac Oncol. 2021. PMID: 33781442 Free article. No abstract available.

2

Multiple primary malignancies involving lung cancer-clinical characteristics and prognosis.

Liu YY, Chen YM, Yen SH, Tsai CM, Perng RP. Liu YY, et al. Among authors: chen ym. Lung Cancer. 2002 Feb;35(2):189-94. doi: 10.1016/s0169-5002(01)00408-1. Lung Cancer. 2002. PMID: 11804692

3

Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.

Chen YM, Shih JF, Lee CS, Chen MC, Lin WC, Tsai CM, Perng RP. Chen YM, et al. Among authors: chen mc. Lung Cancer. 2003 Feb;39(2):209-14. doi: 10.1016/s0169-5002(02)00445-2. Lung Cancer. 2003. PMID: 12581575 Clinical Trial.

4

Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report.

Chen YM, Chen MC, Tsai CM, Perng RP. Chen YM, et al. Among authors: chen mc. Lung Cancer. 2003 Apr;40(1):99-101. doi: 10.1016/s0169-5002(02)00504-4. Lung Cancer. 2003. PMID: 12660014

5

Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms.

Chen YM, Perng RP, Chu H, Tsai CM, Whang-Peng J. Chen YM, et al. Lung Cancer. 2004 Jul;45(1):39-43. doi: 10.1016/j.lungcan.2004.01.002. Lung Cancer. 2004. PMID: 15196733 Free PMC article.

6

Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity.

Chiu CH, Tsai CM, Chen YM, Chiang SC, Liou JL, Perng RP. Chiu CH, et al. Among authors: chen ym. Lung Cancer. 2005 Jan;47(1):129-38. doi: 10.1016/j.lungcan.2004.05.014. Lung Cancer. 2005. PMID: 15603863 Clinical Trial.

7

A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated.

Chen YM, Perng RP, Shih JF, Tsai CM, Whang-Peng J. Chen YM, et al. Lung Cancer. 2005 Mar;47(3):373-80. doi: 10.1016/j.lungcan.2004.08.007. Lung Cancer. 2005. PMID: 15713520 Clinical Trial.

8

Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.

Chou TY, Chiu CH, Li LH, Hsiao CY, Tzen CY, Chang KT, Chen YM, Perng RP, Tsai SF, Tsai CM. Chou TY, et al. Among authors: chen ym. Clin Cancer Res. 2005 May 15;11(10):3750-7. doi: 10.1158/1078-0432.CCR-04-1981. Clin Cancer Res. 2005. PMID: 15897572

9

Lung cancer associated with rheumatoid arthritis does not shorten life expectancy.

Chen CY, Chen YM, Yen SH, Perng RP. Chen CY, et al. Among authors: chen ym. J Chin Med Assoc. 2005 May;68(5):216-20. doi: 10.1016/S1726-4901(09)70210-2. J Chin Med Assoc. 2005. PMID: 15909726 Free article.

10

Phase II randomized trial of tri-weekly versus days 1 and 8 weekly docetaxel as a second-line treatment of advanced non-small cell lung cancer.

Lai CL, Tsai CM, Chiu CH, Wang GS, Su WJ, Chen YM, Perng RP. Lai CL, et al. Among authors: chen ym. Jpn J Clin Oncol. 2005 Dec;35(12):700-6. doi: 10.1093/jjco/hyi191. Epub 2005 Nov 22. Jpn J Clin Oncol. 2005. PMID: 16303792 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,967 results

Search Page

Filters